Edition:
United States

Smith & Nephew PLC (SNN)

SNN on New York Consolidated

36.71USD
18 Sep 2017
Change (% chg)

-- (--)
Prev Close
$36.71
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
402,001
52-wk High
$37.22
52-wk Low
$26.97

Chart for

About

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip... (more)

Overall

Beta: 0.75
Market Cap(Mil.): $15,991.92
Shares Outstanding(Mil.): 437.42
Dividend: 0.25
Yield (%): 1.68

Financials

  Industry Sector
P/E (TTM): -- 31.36 16.21
EPS (TTM): -- -- --
ROI: -- 13.79 14.56
ROE: -- 16.62 13.83

BRIEF-Smith & Nephew partners with Imperial College to develop surgical techniques in sports medicine

* SMITH & NEPHEW AND IMPERIAL COLLEGE PARTNER TO DEVELOP ENHANCED SURGICAL TECHNIQUES IN SPORTS MEDICINE Source text for Eikon: Further company coverage:

Sep 05 2017

Smith & Nephew buoyed by double-digit emerging markets growth

LONDON, July 27 Artificial hip and knee maker Smith & Nephew reported a 3 percent rise in underlying revenue growth in the second quarter, in line with its 3-4 percent forecast for the year, helped by 13 percent growth in emerging markets.

Jul 27 2017

BRIEF-Smith & Nephew posts H1 operating profit of $414 mln

* H1 REVENUE 2.336 BILLION USD VERSUS 2.328 BILLION USD YEAR AGO

Jul 27 2017

BRIEF-Smith & Nephew appoints Angie Risley as chairman elect of remuneration committee

* Appointment of Angie Risley as non-executive director and chairman elect of remuneration committee Source text for Eikon: Further company coverage:

Jul 04 2017

RPT-UPDATE 1-Emerging markets growth puts Smith & Nephew on track for year

LONDON, May 5 Shares in Smith & Nephew rose to a nine-month high on Friday after the artificial hip and knee maker said a strong first quarter, led by growth in emerging markets, put it on track to meet it targets for the year.

May 05 2017

UPDATE 1-Emerging markets growth puts Smith & Nephew on track for year

* Shares rise to nine-month highs (Adds CEO comments, analyst reaction, shares)

May 05 2017

Smith & Nephew says M&A 'not at top of agenda' at the moment

LONDON The chief executive of Smith & Nephew said on Friday that M&A was not at the top of his agenda, as the focus was on driving growth at the artificial knee and hip maker.

May 05 2017

Smith & Nephew says M&A 'not at top of agenda' at the moment

LONDON, May 5 The chief executive of Smith & Nephew said on Friday that M&A was not at the top of his agenda, as the focus was on driving growth at the artificial knee and hip maker.

May 05 2017

Smith & Nephew Q1 revenue rises 3 pct on underlying basis

LONDON, May 5 Smith & Nephew, Europe's biggest artificial hip and knee maker, reported a 3 percent rise in underlying revenue in its first quarter, helped by a return to double-digit growth in emerging markets and a solid performance in knee implants.

May 05 2017

Earnings vs. Estimates